$20.57
-0.54 (-2.56%)
Open$20.97
Previous Close$21.11
Day High$20.98
Day Low$20.20
52W High$25.15
52W Low$16.52
Volume—
Avg Volume671.1K
Market Cap1.47B
P/E Ratio2.92
EPS$5.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+90.4% upside
Current
$20.57
$20.57
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 347.70M | 323.50M | 296.49M |
| Net Income | 229.22M | 191.94M | 100.45M |
| Profit Margin | 65.9% | 62.6% | 33.9% |
| EBITDA | 150.21M | 132.77M | 161.71M |
| Free Cash Flow | — | — | 84.32M |
| Rev Growth | +7.5% | +7.5% | +12.4% |
| Debt/Equity | 0.22 | 0.22 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |